ARCHIVES

Blue Cross, Broder Skirmish On Coverage Of Group C Drugs

This article is from The Cancer Letter archive.

Vol. 15 No. 42 | November 3, 1989

Download PDF Visit The Full Archive

Related Articles

ImClone Offered C225 Deal To Seven Firms Prior To BMS

February 22, 2002

Six Patients Apparently responded To Laetrile, NCI Review Finds; DCT Considers Clinical Trials

September 8, 1978

FDA Advisors: DepoCyt May Test Accelerated Approval Mechanism

November 27, 1998

RFA Available: Chemoprevention Trials

August 5, 1994

Fox Chase-U.Pa. Radiation Dept. Received Contract

October 12, 1979

HHS Secretary Rebukes Task Force Guidelines On Breast Cancer Screening

November 29, 2009